Quantamental Technologies LLC Uro Gen Pharma Ltd. Transaction History

Quantamental Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$21.11 - $34.86 $71,774 - $118,524	-3,400 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$23.83 - $36.44 $72,300 - $110,558	3,034 Added 828.96%	3,400 $81,000
Q2 2019 Aug 12, 2019	SELL	$32.75 - $40.35 $1,113 - $1,371	-34 Reduced 8.5%	366 $13,000
Q1 2019 Apr 29, 2019	BUY	$35.47 - $54.55 $3,547 - $5,455	100 Added 33.33%	400 $15,000
Q4 2018 Jan 28, 2019	BUY	$38.35 - $50.39 $11,505 - $15,117	300 New	300 $13,000

120

39.3M

158K

161K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $282M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.